US$ 29.06
aod9604 dosing frequency subcutaneous injection AOD 9604: Peptide Claims vs Clinical Reality AOD 9604 is marketed as a fat-metabolism peptide derived from a growth hormone fragment, often positioned as “HGH-like” without HGH's side effects. The clinical question Safety and Tolerability of the
Description
MOTS-c promotes fat oxidation through AMPK-mediated lipolysis and targets visceral fat specifically

Water retention and joint stiffness from GH peptides are more pronounced in older adults

There is no human head-to-head bioavailability trial declaring one route superior, so pick the route your protocol specifies and hold it consistently
Track sleep duration and subjective quality to identify any changes

Week-by-Week Timeline Individual responses vary
